Accenture to Acquire Anser Advisory to Expand Capital Project Capabilities
Accenture will help clients more efficiently deliver large infrastructure projects in North America NEW YORK…
Month: June 2023
IGM Announces Proposed Public Offering and Concurrent Private Placement
MOUNTAIN VIEW, Calif., June 21, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (NASDAQ: IGMS) today…
Roivant to Host Investor Call at 8:00 AM ET on Thursday, June 22 to Review Results from the Chronic Period of TUSCANY-2, a Large Global Phase 2b Study of RVT-3101 (Anti-TL1A Antibody) in Ulcerative Colitis
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 21, 2023 (GLOBE NEWSWIRE) —…
Vaxart Encourages All Stockholders of Record as of April 28, 2023 to Vote by June 25, 2023, at 11:59 p.m. ET
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today encourages…
Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023
-Presentations include a late breaking poster from an ongoing Phase 1b study of ALG-000184 demonstrating…
Bon Natural Life Limited Receives NASDAQ Notification Regarding Minimum Bid Deficiency
XI’AN, China, June 21, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
Panbela Announces Closing of Approximately $8.5 Million Public Offering
MINNEAPOLIS, June 21, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive…
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023
— Fourth Quarter and Full Year Revenue of $39.8 Million and $149.3 Million, Respectively, Both…
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
PORTLAND, Maine, June 21, 2023 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
Larimar Therapeutics Set to Join Russell 3000® Index
BALA CYNWYD, Pa., June 21, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
BELTSVILLE, Md., June 21, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company…
Personas Announces Correction to Press Release Announcing Closing of $1.15 Million Non-Brokered Private Placement
Correcting and Replacing“Warrants, the closing price of the Company’s Common Shares on the TSX Venture…
OMV Petrom Wins ISA100 Wireless Excellence in Automation Award
Annual award honors novel application of wireless instrumentation Durham, North Carolina–(Newsfile Corp. – June 21,…
INVESTOR ACTION ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against Tingo Group, Inc. (NASDAQ: TIO); Lead Plaintiff Deadline is August 7, 2023
NEW YORK–(BUSINESS WIRE)–Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation…
Devron Awarded 2023 “Best Machine Learning Company”
NEW YORK–(BUSINESS WIRE)–#AI—Devron, the leader in AI and machine learning for distributed and private data,…
Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical Trials
Debiopharm Innovation Fund and Benchstrength co-lead seed funding round supporting Altis’ AI-powered imaging biomarker platform…
OutSystems Unveils its Generative AI Roadmap to Transform the Way Enterprises Develop, Edit and Extend Mission-Critical Applications
Company shares live demos of its new connector for Azure OpenAI, built in partnership with…
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility…
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility…
Eloxx Pharmaceuticals to Host Investor and Analyst Call on Alport Syndrome
Globally renowned Alport syndrome experts will provide key insights Eloxx recently announced achievement of remission…